what about stats post vaccination for over 65. We also need to include patients with serious underlying condition. There are a lot of factors but the bottom line is vaccines are doing the job. I am surprised they’re thinking of doing another Covid-19’s trial. Maybe if it was for ARDS, maybe.
MSB need Gvhd approved and a partnership deal with heart and back. We need revenue asap. Inflation and interest rate rises, the market will punish stocks that aren’t generating revenue and worst, companies with debt.
We all agree the product works but at the end of the day revenue counts. The longer this drags, expect SP to drop below $1.
geez hate saying that but the person who created the $1 party thread may get his/hers wish.
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-149
-
- There are more pages in this discussion • 757 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |